Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from medgepeptides.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Issues our data pipeline flagged on this vendor's COAs. Each flag points at a specific COA and the reason it was raised.
COA labeled 80.00mg but archived vendor listing (bpc-157-20mg @ 2026-05-25) shows 20.00mg — 75% drift
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|
| 5-Amino-1MQ | 1 | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| BPC-157 | BPC20N 10 09 25 | Freedom Diagnostics | 99.22% | MSLAL | — | View |
| GHK-Cu/KPV/BPC-157/Thymosin Beta-4 | KL80LT12 | Freedom Diagnostics | 99.89% | MS | — | View |
| Epitalon | EPI50A 11 14 25 | Freedom Diagnostics | 99.37% |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| — |
| BPC-157 | 5 | 99.64% | — | — |
| CJC-1295 (NO DAC) | 2 | 99.88% | — | — |
| Epitalon | 2 | 99.37% | — | — |
| GHK-Cu | 2 | 99.77% | — | — |
| Hexarelin | 2 | 99.71% | — | — |
| Ipamorelin | 1 | 99.80% | — | — |
| Ipamorelin/Tesamorelin | 1 | 99.21% | — | — |
| Klow | 1 | — | — | — | — | — |
| LL-37 | 1 | 99.70% | — | — |
| MOTS-C | 1 | 99.59% | — | — |
| NAD+ | 2 | 99.80% | — | — |
| Semax | 1 | 99.19% | — | — |
| SLU-PP-332 | 2 | — | — | — | — |
| Tesofensine | 2 | — | — | — | — |
| Thymosin Alpha-1 | 1 | 99.74% | — | — |
| 2026-01-12 |
| View |
| Hexarelin | HEXSLT12 | Freedom Diagnostics | 99.71% | MS | 2026-01-12 | View |
| Semax | SMX30A 12 29 25 | Freedom Diagnostics | 99.19% | MS | 2026-01-12 | View |
| NAD+ | FNAD100MN 12 22 25 | Freedom Diagnostics | 99.80% | MS | 2026-01-12 | View |
| Epitalon | EPI50A T1 14 25 | Freedom Diagnostics | 99.37% | MS | 2026-01-12 | View |
| LL-37 | LL375LT12 | Freedom Diagnostics | 99.70% | MS | 2026-01-12 | View |
| Ipamorelin | IPA10N 08 19 25 | Freedom Diagnostics | 99.80% | MS | 2026-01-12 | View |
| CJC-1295 (NO DAC) | CND10N 07 26 2S | Freedom Diagnostics | 99.88% | MS | 2026-01-12 | View |
| BPC-157 | BPCTB410 11 24 25-01 | Freedom Diagnostics | 99.61% | MSLAL | 2026-01-12 | View |
| GHK-Cu | GHK50N 10 16 25 | Freedom Diagnostics | 99.77% | MS | 2026-01-12 | View |
| CJC-1295 (NO DAC) | CND10N 07 26 25 | Freedom Diagnostics | 99.88% | MS | 2026-01-12 | View |
| Hexarelin | HEX5LT12 | Freedom Diagnostics | 99.71% | MS | 2026-01-12 | View |
| Tesofensine | 25F 019 | Freedom Diagnostics | — | MS | 2026-01-12 | View |
| MOTS-C | MOTS 11 19 25 J | Freedom Diagnostics | 99.59% | MS | 2026-01-12 | View |
| BPC-157 | BPCTB410 II 24 25-01 | Freedom Diagnostics | 99.61% | MS | 2026-01-12 | View |
| GHK-Cu/KPV/BPC-157/Thymosin Beta-4 | KL80-T12 | Freedom Diagnostics | 99.89% | MS | 2026-01-12 | View |
| Klow | KL80LT12 | Freedom Diagnostics | — | LAL | 2026-01-12 | View |
| GHK-Cu | GHKS0N 10 16 25 | Freedom Diagnostics | 99.77% | MSLAL | 2026-01-12 | View |
| Thymosin Alpha-1 | TAL10LT12 | Freedom Diagnostics | 99.74% | MS | 2026-01-12 | View |
| Ipamorelin/Tesamorelin | 2X-12N 12 18 25 | Freedom Diagnostics | 99.21% | MS | 2026-01-12 | View |
| 5-Amino-1MQ | 25L 040 | Freedom Diagnostics | — | MS | 2026-01-12 | View |
| NAD+ | FNAD1000N 12 22 25 | Freedom Diagnostics | 99.80% | MSLAL | 2026-01-12 | View |
| SLU-PP-332 | 25G 028 | Freedom Diagnostics | — | MS | 2026-01-12 | View |
| Tesofensine | 25E 019 | Freedom Diagnostics | — | MSLAL | 2026-01-12 | View |
| SLU-PP-332 | 25F 023 | Freedom Diagnostics | — | LAL | 2026-01-12 | View |